The role of antiplatelet drugs in the longterm risk of recanalization after endovascular treatment of intracranial aneurysms: Are they safe?

Johannes Platz, Joachim Berkefeld, Erdem Güresir, Volker Seifert & Hartmut Vatter
Objective: Aneurysm recanalization after endovascular treatment (EVT) of intracranial aneurysms remains an unsolved issue. Little is known about the risk-factors contributing to it. Here we assessed if the use of antiplatelet drugs (AP) is associated with aneurysm recanalization following EVT. Methods:[for full text, please go to the a.m. URL]